Argonne National Laboratory

Virtual lecture series finale connects interns to ongoing COVID-19 research

29-Jul-2020 6:55 PM EDT, by Argonne National Laboratory

Newswise — As a final milestone in their summer internships, students participating in the 2020 Office of Science Summer Internship Virtual Lecture Series attended a final seminar on July 22, 2020 that demonstrated how the Department of Energy’s (DOE) National Laboratories are researching COVID-19 and connecting students to the labs’ vibrant science, technology, engineering and mathematics (STEM) communities.

Between June and July 2020, the DOE Office of Science, in collaboration with 17 DOE National Laboratories, hosted a series of virtual seminars to help enrich students’ summer experiences at the laboratories. The lecture series was open to any students who had summer appointments at any of the 17 national labs, with over 5,000 different students invited to participate. Each session covered a different component of the DOE and national labs’ operations, from DOE science and technology endeavors to a panel led by graduate STEM students. The seminar on July 22 was especially timely and impactful, as it addressed DOE’s response to COVID-19.

“NVBL represents the DOE’s continued determination to find solutions to urgent challenges around the world, using some of the most advanced scientific facilities and professionals this country has to offer. Though this challenge is unprecedented, every one of us makes a difference, as we work together to tackle COVID-19.” — Dr. Chris Fall, director of the Office of Science

At the virtual lecture on July 22, scientists in the panel told students how the National Virtual Biotechnology Laboratory (NVBL) is addressing key issues related to the pandemic. The NVBL, a consortium of DOE National Laboratories focused on response to COVID-19, with funding provided by the Coronavirus CARES Act, combines the efforts of all 17 national laboratories.

“NVBL represents the DOE’s continued determination to find solutions to urgent challenges around the world, using some of the most advanced scientific facilities and professionals this country has to offer. Though this challenge is unprecedented, every one of us makes a difference, as we work together to tackle COVID-19,” said Dr. Chris Fall, director of the Office of Science.

Martha Head, director of the Joint Institute for Biological Sciences at Oak Ridge National Laboratory, shared with the students her work on the NVBL’s Molecular Design for Medical Therapeutics project. This project applies supercomputers, nanoscience and other national lab resources to develop therapeutic treatment for COVID-19. Joseph “Pat” Fitch, associate laboratory director for Los Alamos National Laboratory, is working on NVBL’s COVID-19 Testing R&D project to create better diagnostic tests for the virus.

NVBL is also fixing indirect problems stemming from COVID-19. As discussed by Oak Ridge’s Manufacturing Systems Research group leader Lonnie Love during the panel, the NVBL’s Manufacturing project works to improve the supply chain response to COVID-19 with more efficient production and distribution of face masks, ventilators and other essential equipment. Already, Lawrence Livermore National Laboratory has helped the NVBL test new 3D-printed nasopharyngeal swabs.

“I find it wonderful that our interns had a front-row seat to the groundbreaking work we’re undertaking against COVID-19,” said Stephen Streiffer, deputy laboratory director for science and technology for Argonne National Laboratory and co-leader for NVBL. “Unique, first-hand experiences like this pave the way for the next generation of STEM leaders, who will continue to develop scientific solutions for grand challenges worldwide.”

This work was supported in part by the U.S. Department of Energy, Office of Science.

Argonne National Laboratory seeks solutions to pressing national problems in science and technology. The nation’s first national laboratory, Argonne conducts leading-edge basic and applied scientific research in virtually every scientific discipline. Argonne researchers work closely with researchers from hundreds of companies, universities, and federal, state and municipal agencies to help them solve their specific problems, advance America’s scientific leadership and prepare the nation for a better future. With employees from more than 60 nations, Argonne is managed by UChicago Argonne, LLC for the U.S. Department of Energy’s Office of Science.

The U.S. Department of Energy’s Office of Science is the single largest supporter of basic research in the physical sciences in the United States and is working to address some of the most pressing challenges of our time. For more information, visit https://energy.gov/science.




Filters close

Showing results

110 of 3327
Newswise: How to Keep Children Safe from COVID-19 this Fall
Released: 18-Sep-2020 4:15 PM EDT
How to Keep Children Safe from COVID-19 this Fall
Rush University Medical Center

With the new school year started and autumn approaching, Colleen Nash, MD, MPH, Rush University Medical Center, pediatric infectious disease specialist, answers questions parents may have about keeping children safe from COVID, social distancing in the classroom and celebrating Halloween.

Released: 18-Sep-2020 4:05 PM EDT
Claims circulating on social media stating that the common cold or flu can be mistaken for COVID-19 are misleading
Newswise

The claims rely on the faulty assumption that there is no method to distinguish COVID-19 from the common cold and the flu.

Released: 18-Sep-2020 3:35 PM EDT
After developing CRISPR test, UConn researchers validate clinical feasibility for COVID-19 testing
University of Connecticut

In March, researchers in the Department of Biomedical Engineering-- a shared department in the schools of Dental Medicine, Medicine, and Engineering--began to develop a new, low-cost, CRISPR-based diagnostic platform to detect infectious diseases, including HIV virus, the novel coronavirus (SARS-CoV-2).

Newswise:Video Embedded blowin-in-the-wind
VIDEO
Released: 18-Sep-2020 3:10 PM EDT
Blowin' in the wind
University of Utah

University of Utah chemical engineers have conducted an air flow study of the venue that the Utah Symphony performs in to determine the best ways to mitigate the spread of COVID-19 through the emissions of wind instrument players.

Newswise: holman1_toned-1-768x512.jpg
Released: 18-Sep-2020 2:50 PM EDT
Study links rising stress, depression in U.S. to pandemic-related losses, media consumption
University of California, Irvine

Irvine, Calif., Sept. 18, 2020 – Experiencing multiple stressors triggered by the COVID-19 pandemic – such as unemployment – and COVID-19-related media consumption are directly linked to rising acute stress and depressive symptoms across the U.S., according to a groundbreaking University of California, Irvine study. The report appears in Science Advances, published by the American Association for the Advancement of Science.

Newswise: 243389_web.jpg
Released: 18-Sep-2020 10:55 AM EDT
Potential new drug to mitigate SARS-CoV-2 infection consequences
University of Malaga

Scientists from the Department of Cell Biology of the University of Malaga (UMA) and the Andalusian Centre for Nanomedicine and Biotechnology (BIONAND) have made progress in finding new rapid implementation therapies to combat the COVID-19 pandemic, identifying a new drug that could prevent or mitigate the consequences derived from SARS-CoV-2 infection.

Newswise: 243400_web.jpg
Released: 18-Sep-2020 10:40 AM EDT
Most homemade masks are doing a great job, even when we sneeze, study finds
University of Illinois at Urbana-Champaign

Studies indicate that homemade masks help combat the spread of viruses like COVID-19 when combined with frequent hand-washing and physical distancing.

access_time Embargo lifts in 2 days
Embargo will expire: 23-Sep-2020 8:00 AM EDT Released to reporters: 18-Sep-2020 10:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 23-Sep-2020 8:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 18-Sep-2020 8:30 AM EDT
Immunotherapy Drug Development Pipeline Continues Significant Growth in 2020 Despite Global Pandemic Impact
Cancer Research Institute

Despite the impact of the COVID-19 pandemic across the globe, there has been a resurgence of interest in immuno-oncology (I-O) preclinical and clinical development, bringing hope to cancer patients and physicians who treat them.


Showing results

110 of 3327

close
1.57016